Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia Associated With Parkinson's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02702102
What this trial is testing

Imaging Inflammation in Patients With Parkinson's Disease Dementia or Dementia With Lewy Bodies

Who this might be right for
Diffuse Lewy Body DiseaseDementia With Lewy BodiesParkinson's Disease Dementia
Columbia University 5
Large-scale testing (Phase 3)Ended earlyNCT01014858
What this trial is testing

Multi-centre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Newcastle-upon-Tyne Hospitals NHS Trust 64
Not applicableStudy completedNCT02874274
What this trial is testing

Vaccination Uptake (VAX) in PD

Who this might be right for
Parkinson's Disease
NYU Langone Health 164
Testing effectiveness (Phase 2)Active Not RecruitingNCT04148391
What this trial is testing

NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking)

Who this might be right for
Mild Cognitive ImpairmentMild DementiaParkinson Disease+1 more
Aptinyx 99
Testing effectiveness (Phase 2)Study completedNCT01701544
What this trial is testing

Nucleus Basalis Deep Brain Stimulation for Thinking & Memory Problems in Parkinson's.

Who this might be right for
Dementia in Parkinson's Disease
University College, London 6
Early research (Phase 1)WithdrawnNCT03938922
What this trial is testing

Evaluate ENT-01 for the Treatment of Parkinson's Disease Dementia

Who this might be right for
Parkinson DiseaseDementia
Enterin Inc.
Testing effectiveness (Phase 2)Study completedNCT02640729
What this trial is testing

Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia

Who this might be right for
Lewy Body DementiaVisual Hallucinations
Axovant Sciences Ltd. 30
Not applicableStudy completedNCT01944436
What this trial is testing

A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body Disease

Who this might be right for
Lewy Body Disease
Sunnybrook Health Sciences Centre 57
Not applicableNot Yet RecruitingNCT07114354
What this trial is testing

Enhancing Utility of Neuropsychological Evaluation for Earlier and Effective Diagnosis of Dementia in Parkinson's Disease

Who this might be right for
Dementia (Diagnosis)Parkinson Disease Dementia (PDD)Parkinson Disease (PD)
The University of Queensland 275
Not applicableLooking for participantsNCT06147999
What this trial is testing

Impact of a Biophoton Therapy on Patients With Brain Disorders

Who this might be right for
Brain Disorders - Alzheimer's Disease, Dementia, Parkinson's Disease, Traumatic Brain Injury
First Institute of All Medicines 80
Testing effectiveness (Phase 2)Ended earlyNCT02871427
What this trial is testing

Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder

Who this might be right for
Lewy Body DementiaDementia With Lewy BodiesParkinson's Disease Dementia+2 more
Axovant Sciences Ltd. 80
Not applicableLooking for participantsNCT07798700
What this trial is testing

Biofluid Research on Age-Related or Inherited Neurodegeneration

Who this might be right for
Frontotemporal Degeneration (FTD)ALS (Amyotrophic Lateral Sclerosis)Primary Progressive Aphasia (PPA)+12 more
University of Pennsylvania 1,000
Early research (Phase 1)Study completedNCT02281474
What this trial is testing

Nilotinib in Cognitively Impaired Parkinson Disease Patients 001

Who this might be right for
Parkinson's DiseaseParkinson's Disease DementiaDiffuse Lewy Body Disease
Georgetown University 12
Large-scale testing (Phase 3)Study completedNCT03325556
What this trial is testing

Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis

Who this might be right for
Dementia-related Psychosis
ACADIA Pharmaceuticals Inc. 392
Testing effectiveness (Phase 2)Study completedNCT02910102
What this trial is testing

Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia

Who this might be right for
Alzheimer's DiseaseDementia With Lewy BodiesParkinson's Disease Dementia
Axovant Sciences Ltd. 38
Testing effectiveness (Phase 2)Study completedNCT02708186
What this trial is testing

Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)

Who this might be right for
Dementia With Lewy BodiesREM Sleep Behavior DisorderParkinson's Disease Dementia
Axovant Sciences Ltd. 34
Not applicableUnknownNCT04698928
What this trial is testing

The Effect of Repetitive Transcranial Magnetic Stimulation on the Cognition in People With Parkinson's Disease

Who this might be right for
Parkinson Disease With Dementia
Taipei Medical University Shuang Ho Hospital 30
Large-scale testing (Phase 3)Study completedNCT00623103
What this trial is testing

Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)

Who this might be right for
Parkinson's Disease Dementia
Novartis 583
Not applicableStudy completedNCT01102582
What this trial is testing

An Observational Study for the Prevalence of Neuropsychiatric Symptom in Parkinson's Disease Dementia

Who this might be right for
Parkinson's Disease Dementia
The Catholic University of Korea 48
Testing effectiveness (Phase 2)Study completedNCT04739423
What this trial is testing

Clenbuterol (CST-103) Co-administered With Nadolol (CST-107) in Subjects With Neurodegenerative Disorders

Who this might be right for
Mild Cognitive Impairment, Lewy Body Dementia, Parkinson's Disease Rapid Eye Movement Sleep Behavior Disorder, Parkinson's Disease Dementia
CuraSen Therapeutics, Inc. 41
Next Page